Country: United States
Language: English
Source: NLM (National Library of Medicine)
TOBRAMYCIN (UNII: VZ8RRZ51VK) (TOBRAMYCIN - UNII:VZ8RRZ51VK), DEXAMETHASONE (UNII: 7S5I7G3JQL) (DEXAMETHASONE - UNII:7S5I7G3JQL)
Novartis Pharmaceuticals Corporation
OPHTHALMIC
PRESCRIPTION DRUG
INDICATIONS AND USAGE: TOBRADEX® (tobramycin and dexamethasone ophthalmic suspension) is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The particular anti-infective drug in this product is active agains
HOW SUPPLIED: Sterile ophthalmic suspension in 2.5 mL (NDC 0078-0953-40), 5 mL (NDC 0078-0953-25) and 10 mL (NDC 0078-0953-26) dispensers. STORAGE: Store at 8°C to 27°C (46°F to 80°F). Store suspension upright and shake well before using. After opening, TOBRADEX® (tobramycin and dexamethasone ophthalmic suspension) can be used until the expiration date on the bottle. Distributed by: Novartis Pharmaceuticals Corporation East Hanover, New Jersey 07936 © Novartis Revised: June 2021 T2021-78
New Drug Application
TOBRADEX- TOBRAMYCIN AND DEXAMETHASONE SUSPENSION/ DROPS NOVARTIS PHARMACEUTICALS CORPORATION ---------- TOBRADEX (TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION) STERILE DESCRIPTION: TOBRADEX (tobramycin and dexamethasone ophthalmic suspension) is a sterile, multiple dose antibiotic and steroid combination for topical ophthalmic use. The chemical structures for tobramycin and dexamethasone are presented below: Tobramycin Empirical Formula: C H N O Chemical Name: _O_-3-Amino-3-deoxy-α-D-glucopyranosyl-(1→4)-_O_-[2,6-diamino-2,3,6- trideoxy-α-D-_ribo_-hexopyranosyl-(1→6)]-2-deoxy-L-streptamine Molecular Weight: 467.52 g/mol Dexamethasone Empirical Formula: C H FO Chemical Name: 9-Fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione Molecular Weight:392.47 g/mol EACH ML OF TOBRADEX (TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION) CONTAINS: ACTIVES: tobramycin 0.3% (3 mg) and dexamethasone 0.1% (1 mg). PRESERVATIVE: benzalkonium chloride 0.01%. INACTIVES: edetate disodium, hydroxyethyl cellulose, purified water, sodium chloride, sodium sulfate, sulfuric acid and/or sodium hydroxide (to adjust pH), and tyloxapol. ® ® 18 37 5 9 22 29 5 ® CLINICAL PHARMACOLOGY: Corticoids suppress the inflammatory response to a variety of agents and they probably delay or slow healing. Since corticoids may inhibit the body's defense mechanism against infection, a concomitant antimicrobial drug may be used when this inhibition is considered to be clinically significant. Dexamethasone is a potent corticoid. The antibiotic component in the combination (tobramycin) is included to provide action against susceptible organisms. _In vitro_ studies have demonstrated that tobramycin is active against susceptible strains of the following microorganisms: _Staphylococci_, including _S. aureus_ and _S. epidermidis_ (coagulase-positive and coagulase- negative), including penicillin-resistant strains. _Streptococci_, including some of the Group A-beta-hemolytic species, some nonhemolytic species, and some _Streptococcus Read the complete document